Eupraxia Pharmaceuticals Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Eupraxia Pharmaceuticals Inc. now
Current reporting with the operating signal separated from the noise.
Eupraxia Pharmaceuticals Inc.: Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
Investors are testing whether Eupraxia Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Eupraxia Pharmaceuticals Inc.: Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
The story matters when it changes Eupraxia Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Eupraxia Pharmaceuticals Inc. (EPRX) Upgraded to Buy: Here's Why
The story matters when it changes Eupraxia Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Eupraxia Pharmaceuticals Inc. to Present at Multiple Upcoming Investor and Scientific Conferences in April and May 2025
The story matters when it changes Eupraxia Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Eupraxia Pharmaceuticals Inc. Announces Appointment of Bruce Cousins as President & CFO
The story matters when it changes Eupraxia Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.EUPRAXIA PHARMS INC by EUPRAXIA PHARMACEUTICALS INC Stock (OTC:EPRXF), Short Interest Report
Investors are testing whether Eupraxia Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest EPRX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Eupraxia Pharmaceuticals Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →